Furthermore, Epac has been shown to mediate cAMP-induced inhibition of DNA damage repair in lung cancer by promoting the degradation of X-ray repair cross-complementing protein 1 (XRCC1) [56]. The gene discussed is RAPGEF4; the disease is lung carcinoma.